BOOK
Klaus and Fanaroff's Care of the High-Risk Neonate E-Book
Jonathan M Fanaroff | Avroy A. Fanaroff
(2012)
Additional Information
Book Details
Abstract
Stay up to date with recent advances in the NICU with Klaus and Fanaroff's Care of the High-Risk Neonate, 6th Edition. This trusted neonatology reference thoroughly covers the new guidelines, equipment, drugs, and treatments that have greatly increased the chance of survival for high-risk infants. Expert contributors deliver the information you need to stay on top of the technological and medical advances in this challenging field.
- Consult this title on your favorite e-reader with intuitive search tools and adjustable font sizes. Elsevier eBooks provide instant portable access to your entire library, no matter what device you’re using or where you’re located.
- Benefit from the expert advice offered in concise, easy-to-read editorial comments throughout the book.
- Assess your knowledge with comprehensive question-and-answer sections at the end of each chapter.
- Understand the clinical relevance of what you’ve learned with case studies that highlight real-world application.
- Own the reference trusted for nearly 40 years by those who care for at-risk neonates in the dynamic and challenging NICU.
- Get fast access to need-to-know information on drugs used in the NICU, normal values, and much more in the fully updated appendices.
- Keep your knowledge up to date with expanded coverage of evidence-based medicine and the role of networks in generating evidence.
- Stay current with all aspects of neonatal care, including resuscitation, transport, nutrition, respiratory problems and assisted ventilation, and organ-specific care.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| IFC | IFC | ||
| Klaus & Fanaroff’s Care of the High-Risk Neonate | i | ||
| Copyright | ii | ||
| Dedication | iii | ||
| Contributors | v | ||
| Preface | xi | ||
| Contents | xiii | ||
| 1 - Evidence-Based Medicine and the Role of Networks in Generating Evidence | 1 | ||
| THE EVOLUTION OF EVIDENCE-BASED MEDICINE | 1 | ||
| A PRESCRIPTION FOR EVIDENCE-BASED MEDICINE FOCUSED PRACTICE | 1 | ||
| CRITICAL PROGRESS IN GENERATING THE EVIDENCE: THE ROLE OF NEONATAL RESEARCH NETWORKS | 4 | ||
| REFERENCES | 9 | ||
| REFERENCES | 9.e1 | ||
| 2 - Antenatal and Intrapartum Care of the High-Risk Infant | 10 | ||
| IDENTIFICATION OF THE PREGNANCY AT RISK | 10 | ||
| SELECTED DISORDERS OF THE MATERNAL-FETAL INTERFACE | 32 | ||
| QUESTION | 53 | ||
| REFERENCES | 53 | ||
| REFERENCES | 53.e1 | ||
| 3 - Resuscitation at Birth | 54 | ||
| FETAL TRANSITION TO EXTRAUTERINE LIFE | 55 | ||
| QUESTIONS | 69 | ||
| REFERENCES | 70 | ||
| REFERENCES | 70.e1 | ||
| 4 - Recognition, Stabilization, and Transport of the High-Risk Newborn | 71 | ||
| MATERNAL HISTORY | 71 | ||
| PREPARATIONS FOR DELIVERY | 77 | ||
| LABOR AND DELIVERY | 79 | ||
| TRANSITION | 79 | ||
| PHYSICAL EXAMINATION OF THE NEWBORN | 81 | ||
| ROUTINE EVALUATION DURING TRANSITION | 93 | ||
| MANAGEMENT OF THE HIGH-RISK INFANT DURING TRANSITION | 95 | ||
| BREAST FEEDING: EFFECT OF MATERNAL ILLNESS AND DRUGS | 97 | ||
| TRANSPORT | 98 | ||
| RECOMMENDATIONS FOR CARE | 99 | ||
| MATCHING | 103 | ||
| REFERENCES | 104 | ||
| REFERENCES | 104.e1 | ||
| 5 - Size and Physical Examination of the Newborn Infant | 105 | ||
| DETERMINANTS OF FETAL GROWTH | 105 | ||
| THE CONCEPT OF INTRAUTERINE GROWTH RESTRICTION | 106 | ||
| PATTERN OF FETAL GROWTH | 107 | ||
| ANTENATAL ASSESSMENT OF INTRAUTERINE GROWTH | 108 | ||
| EPIDEMIOLOGY AND ETIOLOGY OF FETAL GROWTH RESTRICTION | 109 | ||
| PLACENTAL CONTRIBUTIONS | 111 | ||
| DIMINISHED POTENTIAL: FETAL CONTRIBUTIONS | 112 | ||
| IDENTIFICATION AND MANAGEMENT OF GROWTH RESTRICTION | 113 | ||
| SMALL FOR GESTATIONAL AGE INFANTS | 114 | ||
| CLINICAL PROBLEMS | 115 | ||
| GROWTH AND LONG-TERM OUTCOME | 117 | ||
| LARGE FOR GESTATIONAL AGE | 117 | ||
| PHYSICAL EXAMINATION OF THE NEWBORN INFANT | 118 | ||
| REFERENCES | 131 | ||
| REFERENCES | 131.e1 | ||
| 6 - The Physical Environment | 132 | ||
| PHYSIOLOGIC CONSIDERATIONS | 133 | ||
| PRACTICAL APPLICATIONS | 139 | ||
| DISORDERS OF TEMPERATURE REGULATION | 143 | ||
| INDUCED HYPOTHERMIA | 144 | ||
| WEANING FROM THE INCUBATOR | 146 | ||
| QUESTIONS | 146 | ||
| REFERENCES | 150 | ||
| REFERENCES | 150.e1 | ||
| 7 - Nutrition and Selected Disorders of the Gastrointestinal Tract | 151 | ||
| FLUID | 152 | ||
| ELECTROLYTES | 155 | ||
| TOTAL PARENTERAL NUTRITION | 155 | ||
| ENTERAL NUTRITION | 166 | ||
| FORMULA TYPES | 176 | ||
| NUTRITIONAL ASSESSMENT | 181 | ||
| DUODENAL OBSTRUCTION | 187 | ||
| JEJUNOILEAL ANOMALIES | 187 | ||
| MALROTATION/VOLVULUS | 188 | ||
| MECONIUM ILEUS | 189 | ||
| MECKEL DIVERTICULUM | 189 | ||
| COLONIC LESIONS | 189 | ||
| ABDOMINAL WALL DEFECTS | 191 | ||
| INGUINAL HERNIA | 191 | ||
| BLOOD IN STOOL | 192 | ||
| SPONTANEOUS INTESTINAL PERFORATION | 193 | ||
| CLINICAL FEATURES | 196 | ||
| REFERENCES | 200 | ||
| REFERENCES | 200.e1 | ||
| 8 - Care of the Parents | 201 | ||
| PREGNANCY | 201 | ||
| LABOR AND DELIVERY | 203 | ||
| EFFECTS OF SOCIAL AND EMOTIONAL SUPPORT ON MATERNAL BEHAVIOR | 203 | ||
| THE DAY OF DELIVERY | 204 | ||
| WHEN DOES LOVE BEGIN? | 205 | ||
| CARE OF THE NORMAL INFANT AND PARENTS FOLLOWING BIRTH | 205 | ||
| THE BREAST CRAWL | 205 | ||
| EARLY AND EXTENDED CONTACT FOR PARENTS AND THEIR INFANT | 208 | ||
| THE SICK OR PREMATURE INFANT | 209 | ||
| INTERVENTIONS FOR FAMILIES OF PREMATURE INFANTS | 210 | ||
| CONGENITAL MALFORMATIONS | 215 | ||
| STILLBIRTH OR DEATH OF A NEWBORN | 217 | ||
| SUMMARY | 223 | ||
| REFERENCES | 224 | ||
| REFERENCES | 224.e1 | ||
| 9 - Nursing Practice in the Neonatal Intensive Care Unit | 225 | ||
| DEVELOPMENTAL CARE | 226 | ||
| SKIN CARE | 229 | ||
| PAIN MANAGEMENT IN THE NEONATE | 232 | ||
| VASCULAR ACCESS | 235 | ||
| COMPLICATIONS OF CARE | 239 | ||
| REFERENCES | 243 | ||
| REFERENCES | 223.e1 | ||
| 10 - Respiratory Problems | 244 | ||
| PHYSIOLOGIC CONSIDERATIONS | 244 | ||
| PRACTICAL CONSIDERATIONS | 246 | ||
| NEONATAL PROBLEMS | 248 | ||
| RESPIRATORY DISTRESS SYNDROME | 249 | ||
| GENERAL CLINICAL MANAGEMENT | 252 | ||
| PERSISTENT PULMONARY HYPERTENSION | 254 | ||
| MECONIUM ASPIRATION SYNDROME | 256 | ||
| PNEUMOTHORAX | 258 | ||
| TRANSIENT TACHYPNEA OF THE NEWBORN | 259 | ||
| PULMONARY HEMORRHAGE | 260 | ||
| BRONCHOPULMONARY DYSPLASIA/NEONATAL CHRONIC LUNG DISEASE | 260 | ||
| APNEA IN THE IMMATURE INFANT | 263 | ||
| QUESTIONS | 266 | ||
| REFERENCES | 269 | ||
| REFERENCES | 269.e1 | ||
| 11 - Assisted Ventilation | 270 | ||
| RESPIRATORY FAILURE | 270 | ||
| ENDOTRACHEAL INTUBATION | 271 | ||
| APPLIED PULMONARY MECHANICS | 273 | ||
| CONTINUOUS POSITIVE AIRWAY PRESSURE | 274 | ||
| MECHANICAL VENTILATION | 276 | ||
| ALTERNATIVE MODES OF MECHANICAL VENTILATION | 277 | ||
| CARBON DIOXIDE ELIMINATION | 278 | ||
| OXYGENATION | 279 | ||
| VENTILATOR SETTING CHANGES AND GAS EXCHANGE | 280 | ||
| MONITORING THE INFANT DURING MECHANICAL VENTILATION | 280 | ||
| SPECIAL CIRCUMSTANCES | 282 | ||
| HIGH-FREQUENCY VENTILATION | 283 | ||
| COMPLICATIONS OF ASSISTED VENTILATION | 284 | ||
| EXTRACORPOREAL MEMBRANE OXYGENATION | 285 | ||
| INHALED NITRIC OXIDE | 285 | ||
| SUMMARY | 285 | ||
| QUESTIONS | 285 | ||
| REFERENCES | 288 | ||
| 12 - Glucose, Calcium, and Magnesium | 289 | ||
| GLUCOSE | 289 | ||
| CALCIUM | 299 | ||
| MAGNESIUM | 304 | ||
| METABOLIC BONE DISEASE OF PREMATURITY (FORMERLY OSTEOPENIA–RICKETS OF PREMATURITY) | 305 | ||
| QUESTIONS | 306 | ||
| REFERENCES | 309 | ||
| 13 - Neonatal Hyperbilirubinemia | 310 | ||
| FORMATION, STRUCTURE, AND PROPERTIES OF BILIRUBIN | 310 | ||
| NEONATAL BILIRUBIN METABOLISM | 310 | ||
| NORMAL SERUM BILIRUBIN LEVELS AND THE NATURAL HISTORY OF NEONATAL JAUNDICE | 312 | ||
| DEVELOPMENTAL JAUNDICE | 313 | ||
| AN APPROACH TO THE JAUNDICED INFANT | 314 | ||
| PATHOLOGIC JAUNDICE | 317 | ||
| BILIRUBIN TOXICITY | 324 | ||
| CLINICAL MANAGEMENT | 328 | ||
| TREATMENT | 331 | ||
| PHOTOTHERAPY | 336 | ||
| EXCHANGE TRANSFUSION | 341 | ||
| PHARMACOLOGIC TREATMENT | 342 | ||
| REFERENCES | 345 | ||
| 14 - Infections in the Neonate | 346 | ||
| EPIDEMIOLOGY, RISK FACTORS, AND PRESENTATION | 346 | ||
| EVALUATION AND MANAGEMENT OF NEONATAL SEPSIS | 347 | ||
| REFERENCES | 367 | ||
| REFERENCES | 367.e1 | ||
| 15 - The Heart | 368 | ||
| PHYSIOLOGY AND PATHOPHYSIOLOGY | 368 | ||
| PHYSICAL EXAMINATION | 375 | ||
| IMAGING OF THE NEONATE | 377 | ||
| DIAGNOSTIC GROUPS OF CONGENITAL HEART DISEASE | 385 | ||
| ARRHYTHMIAS IN THE NEONATE | 396 | ||
| PRACTICAL HINTS | 406 | ||
| REFERENCES | 409 | ||
| REFERENCES | 409.e1 | ||
| 16 - The Kidney | 410 | ||
| ANATOMIC DEVELOPMENT | 410 | ||
| FUNCTIONAL DEVELOPMENT | 410 | ||
| EVALUATION | 415 | ||
| SPECIFIC PROBLEMS | 417 | ||
| REFERENCES | 431 | ||
| REFERENCES | 431.e1 | ||
| 17 - Hematologic Problems | 432 | ||
| RED BLOOD CELLS | 432 | ||
| ANEMIA | 436 | ||
| POLYCYTHEMIA | 445 | ||
| ERYTHROCYTE TRANSFUSION IN THE FETUS AND NEWBORN | 446 | ||
| WHITE BLOOD CELLS | 447 | ||
| NEUTROPHIL DISEASES | 448 | ||
| EOSINOPHILIA | 453 | ||
| CHRONIC GRANULOMATOUS DISEASE | 454 | ||
| NEONATAL IMMUNE DEFICIENCIES OF LYMPHOCYTE LINEAGE (T CELL, B CELL, NATURAL KILLER CELL) | 454 | ||
| NEONATAL THROMBOCYTOPENIA | 457 | ||
| COAGULATION SYSTEM IN THE NEONATE | 463 | ||
| BLEEDING IN NEONATES WITH NORMAL PLATELET COUNTS | 466 | ||
| THROMBOSIS | 469 | ||
| REFERENCES | 475 | ||
| REFERENCES | 475.e1 | ||
| 18 - Brain Disorders of the Fetus and Neonate | 476 | ||
| STAGES OF PRENATAL BRAIN DEVELOPMENT | 476 | ||
| FETAL NEUROLOGIC CONSULTATIONS | 477 | ||
| APPROACH TO NEUROLOGIC EXAMINATION OF THE NEWBORN | 490 | ||
| ADDITIONAL EVALUATIONS OF THE NEWBORN INFANT | 500 | ||
| REPRESENTATIVE FETAL AND NEONATAL NEUROLOGIC DISEASES | 504 | ||
| QUESTIONS | 521 | ||
| REFERENCES | 524 | ||
| REFERENCES | 524.e1 | ||
| 19 - The Outcome of Neonatal Intensive Care | 525 | ||
| IMPORTANCE OF FOLLOW-UP FOR HIGH-RISK INFANTS | 527 | ||
| FOLLOW-UP—WHO, WHAT, HOW, AND WHEN | 529 | ||
| EARLY INTERVENTION | 532 | ||
| POINTS TO REMEMBER | 532 | ||
| REFERENCES | 534 | ||
| REFERENCES | 534.e1 | ||
| 20 - Ethical Issues in the Perinatal Period | 535 | ||
| DISCUSSION | 536 | ||
| REFERENCES | 542 | ||
| REFERENCES | 542.e1 | ||
| A-1 - Drugs Usedfor Emergency and Cardiac Indications in Newborns | 543 | ||
| A-2 - Drug Dosing Table | 546 | ||
| B - Drug Compatibility | 563 | ||
| C - Normal Values | 565 | ||
| D - Umbilical Vessel Catheterization | 590 | ||
| E - Conversion Charts | 595 | ||
| F - Selected Radiology of the Newborn | 599 | ||
| Index | 609 |